Covidien Lp
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$11Mgeneral payments (2019-2025)
$589Kresearch payments (2019-2025)
11,915clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Michael Tal | New Haven, CT | Vascular & Interventional Radiology | $742,832.86 |
| Lawrence Lynn | Columbus, OH | $384,600.00 | |
| Eddie Reddick | Enterprise, AL | $306,172.33 | |
| Gregory Piskun | Brooklyn, NY | Hospice and Palliative Medicine (Surgery) | $281,604.44 |
| Harish Gagneja | Austin, TX | Gastroenterology (Internal Medicine) | $149,461.60 |
| Maciej Kieturakis | Mountain View, CA | Surgery | $132,192.51 |
| John Pandolfino | Chicago, IL | Gastroenterology (Internal Medicine) | $110,463.06 |
| Daniel Cottam | Salt Lake City, UT | Surgery | $99,477.22 |
| Amit Mahajan | Falls Church, VA | Internal Medicine | $87,025.18 |
| Joo Hwang | Stanford, CA | Gastroenterology (Internal Medicine) | $79,912.45 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.